Groundbreaking Food Allergy Treatment Research to Be Unveiled at 2024 American Academy of Allergy, Asthma & amp; Immunology Annual Meeting
Media Advisory for Late Breaking Symposium at the 2024 AAAAI Annual Meeting MILWAUKEE, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Renowned allergist Dr. Robert A. Wood, MD FAAAAI, will present detailed findings from a Phase 3 clinical trial that will have significant impact in the world of food... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 19, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Drying your laundry inside could pose a serious risk to your health, expert warns
The common practice could increase your risk of allergic reactions, asthma attacks, weight loss and even lead to hospitalisation in severe cases, according to an expert. (Source: Daily Express - Health)
Source: Daily Express - Health - February 18, 2024 Category: Consumer Health News Source Type: news
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 17, 2024 Category: Pharmaceuticals Source Type: news
FDA Expands Use of Asthma Med Xolair to Treat Food Allergies
FRIDAY, Feb. 16, 2024 -- People threatened by accidental exposure to foods they ' re allergic to may have a new weapon of defense: On Friday, the U.S. Food and Drug Administration expanded the use of the asthma drug Xolair to help prevent... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2024 Category: General Medicine Source Type: news
FDA expands use of asthma drug Xolair to treat severe food allergies
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions (Source: ABC News: Health)
Source: ABC News: Health - February 16, 2024 Category: Consumer Health News Tags: Health Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news
North Carolina biotech tops $400M in funding for asthma treatment
A Chapel Hill company thinks its drug has the potential to be the first oral therapy to treat patients with severe, uncontrolled asthma. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 15, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
Ozone and PM2.5 Exposure is Associated with Nasal Key Driver Gene Expression in People with Asthma
Six key driver genes were identified for ozone and three key drivers for PM2.5 exposure. MILWAUKEE, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Nasal key driver gene expression representing T-cell mediated immune processes is associated with ozone and fine particulate matter (PM2.5) exposure in... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 15, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news
Non-Lesional Filaggrin Expression is Predictive of Asthma Development in Children with Atopic Dermatitis
Low Filaggrin expression in children aged 2 to 3 years old is a significant predictor of school-age asthma. MILWAUKEE, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Filaggrin (FLG) expression in non-lesional skin and observations of the skin barrier can lead to early diagnosis for children with... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news
North Carolina biotech tops $400M in funding for asthma treatment
A Chapel Hill company thinks its drug has the potential to be the first oral therapy to treat patients with severe, uncontrolled asthma. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2024 Category: Biotechnology Authors: Zac Ezzone Source Type: news
My son died from an asthma attack and now I'm campaigning to make inhalers free in England - people shouldn't have to 'pay to breathe'
Donna Smitheman, 44, from Chesterfield, Derbyshire, lost her son, Jordan Ashley Smitheman, 25, in 2023 following an asthma attack. She is now campaigning to make inhalers free (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2024 Category: Consumer Health News Source Type: news
Asthma of the oesophagus: the alarming rise of a rare inflammatory condition
The little-known digestive disease is hard to diagnose but can affect swallowing and require emergency treatmentLisa Thornton was heavily pregnant and in her early 30s when she noticed the feeling of a blockage in her oesophagus, the muscular food pipe that connects the mouth to the stomach. “At the time, I just thought it was just the pregnancy,” says Thornton, now 50, who lives in the New Forest in Hampshire. “I thought it was everything pushing up. But a few years later, things started to get worse.”During a Sunday roast with her family, a chunk of broccoli suddenly lodged in her throat, causing spasms that pers...
Source: Guardian Unlimited Science - February 10, 2024 Category: Science Authors: David Cox Tags: Science Medical research Diets and dieting Life and style Health Allergies NHS GPs Doctors Society Source Type: news
Early-Life Daycare Attendance Potentially Linked to Lower Risk of Asthma and Allergic Diseases
Research shows children attending daycare had clinically significant lower IgE levels and lower rates of food and perennial aeroallergen sensitization MILWAUKEE, Feb. 8, 2024 /PRNewswire-PRWeb/ -- Daycare attendance is protective against food and perennial aeroallergen sensitization... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 8, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news
Conversio Health Delivers Improved Patient Outcomes and Reduced Costs with Groundbreaking COPD and Asthma Disease Management Program
New website for Conversio's disease management program highlights significant improvements in patient care and cost associated with chronic respiratory conditions. SAN LUIS OBISPO, Calif., Feb. 8, 2024 /PRNewswire-PRWeb/ -- Conversio Health, the leading innovator in respiratory disease... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 8, 2024 Category: Pharmaceuticals Source Type: news
